UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018753
Receipt number R000021693
Scientific Title Long term outcome of Endovascular therapy for PAD with intermittent claudication observational prospective multicenter Registry
Date of disclosure of the study information 2015/09/28
Last modified on 2019/04/01 20:34:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long term outcome of Endovascular therapy for PAD with intermittent claudication
observational prospective multicenter Registry

Acronym

ASHIMORI IC REGISTRY

Scientific Title

Long term outcome of Endovascular therapy for PAD with intermittent claudication
observational prospective multicenter Registry

Scientific Title:Acronym

ASHIMORI IC REGISTRY

Region

Japan


Condition

Condition

peripheral artery disease with intermittent claudication

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evalutate the outcome 12 months after Endovascular Treatment(EVT) for PAD patients with claudication. Outcomes are efficacy and safty of EVT and, the efficary includes the patency of index lesion and the change of leg symptoms.
We investigate long term outcome 3years after EVT.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Primary patency rate of target vessel 12 months after EVT

Key secondary outcomes

Improvement of leg symptom 12 months after EVT.
Major adverse events (MAE) occurring within 3years after index treatment. MAE is defined as death, myocardial infarction (Q-wave and non-Q-wave), stroke, TVR, or major amputation of index limb
Improvement of leg symptom assessed by 6 minutes walking test
The change in femoral and the below-knee
circumference


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Patients diagnosed with PAD
2)Patients aged 20 years or older when providing consent
3)Patients providing written consent indicating understanding of and agreement to participate in the study, and willing to undergo follow up at 1, 2, and 3 years after index treatment
4)Patients with an index limb ABI equal to or lower than 0.9, or definite diagnosis of PAD in accordance with ACCF/AHA guidelines if ABI is greater than 0.9.
5)Patients have symptoms including claudication and rest leg pain.

Key exclusion criteria

1)Terminally ill patients expected to live less than one year EVT
2)Patients with ischemic ulcer or gangreen
3)Patients with untreated coagulation or significant bleeding disorders and patients unable to receive anticoagulation or antiplatelet treatment
4)Patients who are or may be pregnant or lactating
5)Patients whose treatment side leg has already been amputated above the ankle
6)to participate in other clinical trials that could possible affect the scientific validity of this study

Target sample size

600


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Ito

Organization

Okayama University

Division name

Department of Cardiovaclar medicine

Zip code

700-8558

Address

2-5-2 SHIKATACHO KITAKU OKAYAMA CITY

TEL

086-235-7351

Email

hiromail1979@yahoo.co.jp


Public contact

Name of contact person

1st name Hironobu
Middle name
Last name Toda

Organization

Okayama University

Division name

Department of Cardiovaclar medicine

Zip code

700-8558

Address

2-5-2 SHIKATACHO KITAKU OKAYAMA CITY

TEL

086-235-7351

Homepage URL


Email

hiromail1979@yahoo.co.jp


Sponsor or person

Institute

Okayama University
Department of Cardiovasclar medicine

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Ethics Committee

Address

2-5-1 Shikatatyo Kitaku Okayama City

Tel

086-235-6938

Email

mae6605@adm.okayama-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 09 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 09 Month 28 Day

Date of IRB

2015 Year 09 Month 29 Day

Anticipated trial start date

2016 Year 01 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is prospective cohort study.We investigate patients performed EVT from Jan, 2016 to Mar 2021.


Management information

Registered date

2015 Year 08 Month 21 Day

Last modified on

2019 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021693


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name